<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="other"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">F1000Res</journal-id><journal-id journal-id-type="iso-abbrev">F1000Res</journal-id><journal-title-group><journal-title>F1000Research</journal-title></journal-title-group><issn pub-type="epub">2046-1402</issn><publisher><publisher-name>F1000 Research Limited</publisher-name><publisher-loc>London, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39931159</article-id><article-id pub-id-type="pmc">PMC11809632</article-id><article-id pub-id-type="doi">10.12688/f1000research.134121.6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Opinion Article</subject></subj-group><subj-group><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Viral interactions with host factors (TIM-1, TAM -receptors, Glut-1) are related to the disruption of glucose and ascorbate transport and homeostasis, causing the haemorrhagic manifestations of viral haemorrhagic fevers.</article-title><fn-group content-type="pub-status"><fn><p>[version 6; peer review: 2 approved]</p></fn></fn-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Chicano Wust</surname><given-names>Ivan</given-names></name><role content-type="http://credit.niso.org/">Conceptualization</role><role content-type="http://credit.niso.org/">Data Curation</role><role content-type="http://credit.niso.org/">Formal Analysis</role><role content-type="http://credit.niso.org/">Funding Acquisition</role><role content-type="http://credit.niso.org/">Investigation</role><role content-type="http://credit.niso.org/">Methodology</role><role content-type="http://credit.niso.org/">Project Administration</role><role content-type="http://credit.niso.org/">Resources</role><role content-type="http://credit.niso.org/">Software</role><role content-type="http://credit.niso.org/">Supervision</role><role content-type="http://credit.niso.org/">Validation</role><role content-type="http://credit.niso.org/">Visualization</role><role content-type="http://credit.niso.org/">Writing &#x02013; Original Draft Preparation</role><role content-type="http://credit.niso.org/">Writing &#x02013; Review &#x00026; Editing</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1574-8794</contrib-id><xref rid="c1" ref-type="corresp">a</xref><xref rid="a1" ref-type="aff">1</xref></contrib><aff id="a1">
<label>1</label>Universidad Nacional de Educacion a Distancia, Madrid, Community of Madrid, Spain</aff></contrib-group><author-notes><corresp id="c1">
<label>a</label>
<email xlink:href="mailto:ichw8000@gmail.com">ichw8000@gmail.com</email>
</corresp><fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>9</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>518</elocation-id><history><date date-type="accepted"><day>2</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2024 Chicano Wust I</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="f1000research-12-175501.pdf"/><abstract><p>The haemorrhagic features of viral haemorrhagic fevers may be caused by common patterns of metabolic disturbances of the glucose and ascorbate homeostasis. Haemorrhages and vasculature disfunctions are a clinical feature not only of viral haemorrhagic fevers, but also in scurvy, diabetes and thrombotic microangiopathic haemolytic anaemia. Interestingly, the expression of glucose and ascorbate transporter Glut-1 on the erythrocyte membrane is associated with the inability to synthesize ascorbate and is restricted to that very species that are susceptible to filoviruses (primates, humans and fruit bats). Glut-1 may play a pivotal role in haemorrhagic fever pathogenesis. TIM-1 and TAM receptors have been recognized to enhance entry of Ebola, Lassa and Dengue viruses and viral interferences with TIM-1 could disturb its function, disturbing the expression of Glut-1. In those species not able to synthesize ascorbate and expressing Glut-1 on erythrocytes virus could interact with Glut-1 or other functionally related protein, and the influx of glucose into the cells would be severely impaired. As a consequence, transient hyperglycemia and a marked oxidative stress coupled with the high levels of glucose in plasma would be established, and then promote the activation of NF&#x02013;&#x003ba;B transcription, exacerbating a pro-inflammatory response mediated by cytokines and chemokines: The inability to synthesize ascorbate is an Achilles Heel when trying to counteract the oxidative stress.</p></abstract><kwd-group kwd-group-type="author"><kwd>Ebola virus</kwd><kwd>Lassa virus</kwd><kwd>Dengue virus</kwd><kwd>haemorrhagic fevers</kwd><kwd>glucose</kwd><kwd>ascorbate</kwd><kwd>oxidative stress</kwd></kwd-group><funding-group><funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement></funding-group></article-meta><notes notes-type="version-changes"><sec sec-type="version-changes"><label>Revised</label><title>Amendments from Version 5</title><p>The text was re-organized: an introduction and a conclusion were included. Other families or viruses causing hameorrhagic fevers were considered.</p></sec></notes></front><body><sec sec-type="intor" id="sec1"><title>Introduction</title><p>Viral haemorrhagic fevers are characterized by fever and bleeding disorders and can progress to high fever, shock and death in many cases. Filoviruses constitute a family of RNA Viruses, causing severe haemorrhagic fever disease in human an non-human primates, represented by the the Genus Marburgvirus (MARV), with one species, and Ebolavirus (EBOV), which encompasses at least four species of viruses, named after the locations were the first Filovirus outbreaks were registered, including experimental facilities out of the natural geographical range: Zaire Ebolavirus, Sudan Ebolavirus, Bundibugyo Ebolavirus and Reston Ebolavirus (named after the experimental facility were macaques carrying the virus were imported in Reston, Virginia, USA). Other viruses causing haemorrhagic fever syndromes, at least in humans, include the families of Arenaviruses (including Old World Arenaviruses like Lassa haemorrhagic fever virus (LHFV), and New World Arenaviruses (like Guaranito (GHFV), Jun&#x000ed;n (JHFV) or Machupo (MHFV) viruses); Bunyaviruses like the Crimean-Congo haemorrhagic fever virus (CCHFV); Flaviviruses like the Dengue virus (DENV), which causes severe haemorrhagic fever only in some cases, under not yet determined circumstances; and Hantaviruses (HANV), like the viruses causing the haemorrhagic fever with renal syndrome (HFRS).</p><p>In the present opinion article, it will be disclosed that the haemorrhagic features of viral haemorrhagic fevers in general, and those caused by Lassa virus, dengue virus and especially Ebola virus, in particular, are caused by common patterns of metabolic disturbances of the glucose and ascorbate homeostasis. According to the experimental data available and some clues pointed out in literature, this work or opinion article will focus on the possible pathophysiological process that governs haemorrhagic fevers caused by Filoviruses, and from that point, expand on the hypothesis to other viruses for which experimental data suggest some commonalty in factors driving the possible pathophysiology of haemorrhagic fevers caused by filoviruses, as is the case of Lassa virus and Dengue virus. Other haemorrhagic fever-causing viruses, as the New World Arenaviruses (GHFV, JHFV, MHFV, for example), Bunyaviruses like the CCHFV, or Hantaviruses, could be classified as being governed by other pathophysiological metabolic mechanisms, although interactions of these viruses with the same host factors considered for Filoviruses, Lassa and Dengue viruses (as is supported by literature), cannot yet be excluded, although theses interactions are not yet supported by experimental research.</p></sec><sec id="sec2"><title>The haemorrhagic features of viral haemorrhagic fevers are caused by common patterns of metabolic disturbances of the glucose and ascorbate homeostasis</title><p>Disruption of glucose and ascorbate homeostasis could be the reason of both enhanced inflammatory cytokine storming and haemorrhagic manifestations at the level of endothelial cells and vasculature injury.
<sup>
<xref rid="ref1" ref-type="bibr">1</xref>
</sup>
<sup>&#x02013;</sup>
<sup>
<xref rid="ref5" ref-type="bibr">5</xref>
</sup> Endothelial damage during EBOV infection with no evidence of direct endothelial cytolysis has previously been described,
<sup>
<xref rid="ref6" ref-type="bibr">6</xref>
</sup> reinforcing the idea that other indirect mechanisms governing vasculature injury are present. Intracellular ascorbic acid has been considered as an enhancer of nitric oxide (NO) synthesis
<sup>
<xref rid="ref7" ref-type="bibr">7</xref>
</sup> and the macromolecular permeability of cultured human umbilical vein endothelial cell monolayers was decreased significantly in culture medium containing L-ascorbic acid and L-ascorbic acid 2-phosphate.
<sup>
<xref rid="ref8" ref-type="bibr">8</xref>
</sup> Apoptosis in endothelial cells can be induced by hyperglycemia and ascorbate helps to prevent endothelial dysfunction, stimulates type-IV collagen synthesis and enhances cell proliferation. Haemorrhages and vasculature disfunctions are a clinical feature not only of viral haemorrhagic fevers, but also in scurvy, diabetes and thrombotic microangiopathic haemolytic anaemia. Inflammatory cytokine concentrations were found to be acutely increased by hyperglycaemia in humans,
<sup>
<xref rid="ref4" ref-type="bibr">4</xref>
</sup>
<sup>,</sup>
<sup>
<xref rid="ref5" ref-type="bibr">5</xref>
</sup> which has been suggested as the causative role in the vasculature disorders and immune activation of diabetes. Hypoascorbinaemia and diabetes mellitus share several clinical symptoms including microangiopathy, capillary hyperperfusion and haemorrhages.</p></sec><sec id="sec3"><title>Microangiopathic haemolytic anemia: a viral haemorrhagic fever without virus?</title><p>An early description by Symmers in 1952 of the thrombotic microangiopathic haemolytic anaemia,
<sup>
<xref rid="ref9" ref-type="bibr">9</xref>
</sup> which extraordinarily fits the haemorrhagic and vascular manifestations of filovirus haemorrhagic fever (FHF), included haemorrhagic manifestations in the form of widespread purpura. As described by Symmers, &#x0201c;
<italic toggle="yes">there might be haemorrhage from any of the orifices of the body</italic>&#x0201d;. A prodromal period of fever, muscle and joint pains and vague abdominal pain existed and included also mental confusion and neurological symptoms. The parallel of the thrombotic microangiopathic haemolytic anaemia with the filovirus pathological manifestations is important and would open-up the consideration of the haemorrhagic fever disease as a pathophysiological process driven by a mechanism different from the viral lysis that shares commonalties with metabolic and haematological diseases pivoting on the role of blood cells as central players of the homeostasis.</p><sec id="sec4"><title>Glucose and ascorbate metabolism as an Achilles&#x02019; heel in filovirus haemorrhagic fevers (FHF)</title><p>Several receptor candidates have been proposed as mediators for filovirus entry and several attempts to develop a vaccine have been pursued but there is no suitable definitive biological explanation of the violence of the illness manifestations, nor are well defined the factors underlying the differences in illness severity between viruses and within the species range. Whereas many experimental data are available and have rendered important descriptive and molecular information, there is not an integrative and comprehensive perspective. A better comprehension of the virus pathophysiology could help in developing a treatment strategy. According to literature major symptoms of EBOV disease include a maculopapular rash and mucosal haemorrhage. It begins unspecific with fever, asthenia, diarrhea, headaches, myalgia, arthralgia, vomiting and abdominal pain and disease course develops sharply and resolves in survival or death in the course of approximately 3 weeks. Massive bleeding along with fluid distribution problems, disseminated intravascular coagulation and focal necrosis are observed in fatal cases. Arthralgia, asthenia, and neurological disorders, as dysesthesias, are often sequelae in the convalescence, which lasts weeks to months. Main features of EBOV haemorrhagic fevers can be consulted in available literature.
<sup>
<xref rid="ref10" ref-type="bibr">10</xref>
</sup>
<sup>&#x02013;</sup>
<sup>
<xref rid="ref14" ref-type="bibr">14</xref>
</sup>
</p><p>Glucose transporter 1 or Glut 1, also known as solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1), is a
<ext-link xlink:href="https://en.wikipedia.org/wiki/Uniporter" ext-link-type="uri">uniporter</ext-link>
<ext-link xlink:href="https://en.wikipedia.org/wiki/Protein" ext-link-type="uri">protein</ext-link> that in humans is encoded by the
<italic toggle="yes">SLC2A1</italic>
<ext-link xlink:href="https://en.wikipedia.org/wiki/Gene" ext-link-type="uri">gene</ext-link>.
<sup>
<xref rid="ref15" ref-type="bibr">15</xref>
</sup> Glut 1
<ext-link xlink:href="https://en.wikipedia.org/wiki/Facilitated_diffusion" ext-link-type="uri">facilitates</ext-link> the transport of
<ext-link xlink:href="https://en.wikipedia.org/wiki/Glucose" ext-link-type="uri">glucose</ext-link> across the
<ext-link xlink:href="https://en.wikipedia.org/wiki/Cell_membrane" ext-link-type="uri">plasma membranes</ext-link> of mammalian cells.
<sup>
<xref rid="ref16" ref-type="bibr">16</xref>
</sup> Glut 1 is responsible for the low level of basal glucose uptake required to sustain glucolysis and respiration in all cells. Glut 1 is also a major receptor for uptake of vitamin C (ascorbate), especially in non-ascorbate producing mammals as part of an adaptation to compensate by participating in a vitamin C recycling process. In mammals that do produce vitamin C, Glut 4 is often expressed instead of Glut 1.
<sup>
<xref rid="ref17" ref-type="bibr">17</xref>
</sup> Interestingly, and this is a key point of the hypothesis disclosed by this opinion article, expression of Glut-1 on the erythrocyte membrane is associated with the inability to synthesize ascorbate
<sup>
<xref rid="ref18" ref-type="bibr">18</xref>
</sup> and is restricted to that very species that are susceptible to filoviruses or are considered to be the reservoir of the virus in nature (primates, humans and fruit bats). Glucose and ascorbate metabolism represent probably an Achilles&#x02019; heel in FHF and Glut-1 may play a pivotal role in haemorrhagic fever pathogenesis. In other words, Glut-1 on erythrocytes and inability to synthesize ascorbate may account for the pathophysiology of filovirus haemorrhagic fevers in susceptible species. Ebola and Marburg viruses cause haemorrhagic fever in human and non-human primates. Guinea pigs are frequently used as an animal model after a trivial virus strain adaptation. Fruit bats are considered the reservoir of filoviruses in nature.
<sup>
<xref rid="ref19" ref-type="bibr">19</xref>
</sup> Extraordinary mechanisms regarding glucose absorption and transport are displayed by some fruit bats in which serological evidence to Ebola virus was confirmed or Marburg virus was isolated. Pigs,
<sup>
<xref rid="ref20" ref-type="bibr">20</xref>
</sup>
<sup>,</sup>
<sup>
<xref rid="ref21" ref-type="bibr">21</xref>
</sup> which develop symptomless infection by filoviruses differ from the inability of other species to synthesize ascorbate and the presence of Glut-1 on the erythrocyte membranes. Thus, filoviruses in those species expressing the glucose and ascorbate transporter Glut-1 on erythrocytes and unable to synthesize ascorbate, would cause pathophysiological changes that account for the severity of the filoviral haemorrhagic fevers, by means of a virus-driven disruption or overwhelming of ascorbate and/or glucose homeostasis. The inability to synthesize ascorbate could represent an Achilles&#x02019; heel in counteracting the exacerbated inflammatory response
<sup>
<xref rid="ref22" ref-type="bibr">22</xref>
</sup> during EBOV haemorrhagic fever. Transport of dehydroascorbic acid (DHA) from plasma is coupled with its reduction with glutathione (GSH) and NADH. Erythrocytes, with the highest level of Glut-1 expression, regulate the concentrations of ascorbate in plasma by the influx of DHA and efflux of DHA and ascorbate. Glucose and DHA compete for the same transporter and as plasma concentrations of D-glucose are quite higher than DHA concentrations, DHA uptake is more important when ascorbate is rapidly oxidized outside the cells, much like in areas of inflammation, as during FHF.</p></sec><sec id="sec5"><title>
<italic toggle="yes">In vitro</italic> evidence about interactions of Glut-1 with filovirus glycoproteins</title><p>Viral interactions of filoviruses, or interferences, with Glut-1, specially on the erythrocyte membrane could be hypothesized. This might account for the pathophysiological changes during infection. In favor of direct glycoprotein interactions with Glut-1 are the experiments demonstrating inhibition of EBOV-glycoprotein mediated entry by cytokalasin B,
<sup>
<xref rid="ref23" ref-type="bibr">23</xref>
</sup> which is a potent inhibitor of glucose and DHA influx transport in mammalian cells and rather than as agent impairing microfilament function should be considered as an inhibitor of Glut-1, having being used as such for studies on HTLV-1 and HTLV-2 entry,
<sup>
<xref rid="ref24" ref-type="bibr">24</xref>
</sup> retroviruses that use Glut-1 as a receptor for virus entry. Interestingly, there is some sequence homology between HTLV-1 and HTLV-2 glycoproteins and filoviruses glycoprotein (see
<xref rid="f1" ref-type="fig">
Figure 1</xref>). As cytokalasin B exerts its inhibitory effect by docking at the positively charged endofacial pocket 3 A of Glut-1,
<sup>
<xref rid="ref25" ref-type="bibr">25</xref>
</sup> mutagenesis of this site should be tested and its influence on Ebola virus glycoprotein interactions and entry into the cell. Also in favor of direct glycoprotein interactions with Glut-1 are the facts that Phosphoinositide-3 kinase-Akt pathway controlls celular entry of Ebola virus
<sup>
<xref rid="ref26" ref-type="bibr">26</xref>
</sup>: inhibition of PI3K, Akt or Rac1 disrupted normal uptake of virus particles into cells; and cytokine stimulation promotes glucose uptake via phosphatidil inositol-3 kinase/Akt regulation of Glut-1 activity and trafficking
<sup>
<xref rid="ref27" ref-type="bibr">27</xref>
</sup>: Inihibition of mTOR/RAPTOR by ripamycin greatly diminished glucose uptake suggesting Akt-stimulated mTOR/RAPTOR may promote Glut-1 transporter activity.</p><p>On the other hand, the integral protein stomatin, in the lipid rafts of the erythrocyte, regulates the switch from glucose to DHA transport, regulating the substrate preference of the transporter.
<sup>
<xref rid="ref16" ref-type="bibr">16</xref>
</sup> Stomatocytosis, after which the protein stomatin is named, is a haemolytic condition with substantial intravascular haemolysis.</p><fig position="float" fig-type="figure" id="f1"><label>Figure 1. </label><caption><title>A, B. Basic Local Alignment Search Tool blastp 2.2.28+ for non-redundant protein sequences (restricted to viruses and excluding retroviruses) with significant homology to the glycoprotein sequence of HTLV-1 (GenBank AAB42125 173aa).</title><p>Tree views by the neighbor joining method of the aligned sequences (Blastp 2.2.28+). Fast minimum evolution. Max sequence difference, 0,85, Grishin distance.</p></caption><graphic xlink:href="f1000research-12-175501-g0000" id="gr1" position="float"/></fig></sec><sec id="sec6"><title>TIM-1 receptor and TAM family of receptors as a link between viral interactions with host factors and disruption of glucose and ascorbate transport and homeostasis</title><p>EBOV has very broad cell tropism and it may bind to multiple attachment factors, among which are numerous lectins (DC-SIGN/L-SIGN, MGL, LSECtin and &#x003b2;1 integrins. Along with these attachment factors three main receptor candidates have been proposed as mediators for Ebola virus entry:
<list list-type="simple"><list-item><label>-</label><p>NPC1 was identified as an endosome-associated receptor for filovirus entry. This protein is required for filovirus entry and confers susceptibility to filovirus infection when expressed in non-permissive reptilian cells.
<sup>
<xref rid="ref28" ref-type="bibr">28</xref>
</sup>
</p></list-item><list-item><label>-</label><p>The TAM receptor Axl, which has been proven to enhance Ebola virus particles macropinocytosis.
<sup>
<xref rid="ref29" ref-type="bibr">29</xref>
</sup>
</p></list-item><list-item><label>-</label><p>TIM-1.
<sup>
<xref rid="ref30" ref-type="bibr">30</xref>
</sup>
<sup>,</sup>
<sup>
<xref rid="ref31" ref-type="bibr">31</xref>
</sup> It was published that T-cell Ig and mucin domain 1 (TIM-1) binds to the receptor binding domain of the Zaire Ebola virus (EBOV) glycoprotein, and ectopic TIM-1 expression in poorly permissive cells enhances EBOV infection by 10-
to 30-fold.
</p></list-item></list>
</p><p>Interestingly, it has recently been published that TIM-1 mediates also a dystroglycan independent entry of Lassa virus.
<sup>
<xref rid="ref32" ref-type="bibr">32</xref>
</sup> It has been pointed out that &#x0201c;a growing number of enveloped viruses are now appreciated to enter some cell populations through phosphatidylserine (PtdSer) receptor interactions&#x0201d;.
<sup>
<xref rid="ref33" ref-type="bibr">33</xref>
</sup>
<sup>,</sup>
<sup>
<xref rid="ref34" ref-type="bibr">34</xref>
</sup> The TIM receptors directly interact with PtdSer on apoptotic bodies or membrane-associated viruses,
<sup>
<xref rid="ref35" ref-type="bibr">35</xref>
</sup>
<sup>&#x02013;</sup>
<sup>
<xref rid="ref38" ref-type="bibr">38</xref>
</sup> whereas the TAM receptors bind to one of two serum proteins, Gas6 or protein S, which, in turn, bind to PtdSer.
<sup>
<xref rid="ref39" ref-type="bibr">39</xref>
</sup>
<sup>&#x02013;</sup>
<sup>
<xref rid="ref41" ref-type="bibr">41</xref>
</sup>
</p><p>Regarding other virus associated with haemorrhagic manifestations, as is dengue virus (DENV), the same TIM and TAM families of phosphatidylserine receptors have been found to mediate dengue virus entry.
<sup>
<xref rid="ref42" ref-type="bibr">42</xref>
</sup> Thus, TIM-1 has been recognized to enhance entry of EBOV, DENV and LHFV, that are characterized by the haemorrhagic manifestations in the illness they can cause.</p><p>And it has recently been found that TIM-3 expression decreases Glut 1 expression in Jurkat T cells at resting state and at an early time point of activation.
<sup>
<xref rid="ref43" ref-type="bibr">43</xref>
</sup> TIM-1 is preferentially expressed on
<ext-link xlink:href="https://en.wikipedia.org/wiki/Th2_cell" ext-link-type="uri">Th2 cells</ext-link> and has been identified as a stimulatory molecule for
<ext-link xlink:href="https://en.wikipedia.org/wiki/T-cell" ext-link-type="uri">T-cell
</ext-link> activation.
<sup>
<xref rid="ref44" ref-type="bibr">44</xref>
</sup> TIM-3 is preferentially expressed on Th1 and Tc1 cells and functions as an inhibitory molecule, which mediates apoptosis of Th1 and Tc1 cells.
<sup>
<xref rid="ref45" ref-type="bibr">45</xref>
</sup> TIM-4 is preferentially expressed on
<ext-link xlink:href="https://en.wikipedia.org/wiki/Antigen-presenting_cell" ext-link-type="uri">antigen-presenting cells</ext-link>, modulating the
<ext-link xlink:href="https://en.wikipedia.org/wiki/Phagocytosis" ext-link-type="uri">phagocytosis</ext-link> of
<ext-link xlink:href="https://en.wikipedia.org/wiki/Apoptotic" ext-link-type="uri">apoptotic</ext-link> cells by interacting with
<ext-link xlink:href="https://en.wikipedia.org/wiki/Phosphatidylserine" ext-link-type="uri">phosphatidylserine</ext-link> (PS) exposed on apoptotic cell surface.
<sup>
<xref rid="ref35" ref-type="bibr">35</xref>
</sup> In addition to TIM-1, TIM-4 has been shown to augment EBOV entry comparably to TIM-1.
<sup>
<xref rid="ref46" ref-type="bibr">46</xref>
</sup>
</p><p>A key point of the present opinion is that TIM-1, a host factor that has been found to be receptor for Lassa virus, dengue virus and EBOV, could increase the expression of Glut-1 and that there could be a link between glucose and ascorbate transport, viral interactions with TIM-1 and haemorrhagic manifestations of haemorrhagic fevers. Currently it has been described influence of TIM-3 on the expression of Glut 1 but not for TIM-1. On the other hand the mechanism responsible of the haemorrhagic manifestations of haemorrhagic fevers is an unclear matter and no general features have yet been described of a general pathophysiological mechanism. In relation with their natural function, as TIM-1 is a stimulatory molecule for cell activation and TIM-3 functions as an inhibitory molecule, and considering that TIM-3 has been found to decrease Glut 1 expression in Jurkat T cells, it is to expect that TIM-1, in the inverse direction as it does TIM-3, increases the expression of Glut-1. This should be matter of further experimental research. As the key factor TIM-1 would enhance the expression of Glut-1 and the glucose and ascorbate transport, viral interferences with TIM-1 could disturb its function and disturb the expression of Glut-1 or disturb the ascorbate and glucose transport. This would imply a connection between Glut-1, glucose and ascorbate transport, haemorrhagic manifestations, which are linked to oxidative stress, disruption of glucose and ascorbate homeostasis, and the role of TIM family members as mediators of viral entry in those viruses that cause haemorrhagic syndromes and haemorrhagic fevers. If direct interactions of filoviral glycoproteins with Glut-1 could be demonstrated, it could partially explain the differences in severity of the disease manifestations in Ebola and Lassa infections and others.</p><p>On the other hand, TAM receptors, as is Axl, have been found to enhance entry of EBOV and DENV and it has been recently confirmed that endogenous expression of Axl does not actually enhance viral entry of LHFV in the presence of fully functional alpha dystroglycan receptor (&#x003b1;-DG receptor) but it strongly augments viral infection in the absence of &#x003b1;-DG.
<sup>
<xref rid="ref47" ref-type="bibr">47</xref>
</sup> And it has been described that Gas6&#x02013;Axl receptor signalling is regulated by glucose in vascular smooth muscle cells.
<sup>
<xref rid="ref48" ref-type="bibr">48</xref>
</sup> The direct or indirect interaction of Axl with Glut-1 could be hypothesized basing on this finding that the physiological function of Axl is regulated by glucose. Akt-mTOr promotes Glut-1 transporter activity and recycling and can prevent Glut-1 internalization
<sup>
<xref rid="ref27" ref-type="bibr">27</xref>
</sup> and, according to Cavet and colleagues,
<sup>
<xref rid="ref48" ref-type="bibr">48</xref>
</sup> glucose exerted powerful effects on Gas6&#x02013;Axl signaling, with greater activation of Akt and mTOR in low glucose and greater activation of ERK 1
<sans-serif>/</sans-serif>2 in high glucose. Akt-mTOr has been proven as key regulator of Zaire Ebola virus entry and activation of Ras-MAPK pathway, of which ERK1/2 is an activator, stimulates Ebola virus production from persistent infection.
<sup>
<xref rid="ref49" ref-type="bibr">49</xref>
</sup> These findings add to the hypothesis of the pivotal role of glucose, transporters and plasma levels in Filovirus disease.</p></sec><sec id="sec7"><title>Other haemorrhagic fever-causing viruses</title><p>As it has been mentioned in the introduction, for other haemorrhagic fever-causing viruses, there is no evidence in literature for the virus interactions with the host factors considered in this opinion article that have a key role in the present hypothesis. For example, for hantaviruses causing the haemorrhagic fever with renal syndrome, interactions with B1 and b3 integrins could be an explanation of the pathophysiological process at the level of endothelial cells and vasculature injury. Since beta 3 integrin are critical adhesive receptors on platelets and endothelial cells and regulate both vascular permeability and endothelial activation and adhesion, the use of these receptors by hantaviruses is likely to be fundamental to hantavirus pathogenesis.
<sup>
<xref rid="ref68" ref-type="bibr">50</xref>
</sup> However, other authors
<sup>
<xref rid="ref69" ref-type="bibr">51</xref>
</sup> point out that despite the long-standing presumption that beta 3 and beta 1 integrins are the major HANV entry receptors, rigorous genetic loss-of-function evidence supporting their requeriment is lacking. According to theses authors the loss of beta 3 integrin, beta 1 integrin and/or decay-accelarating factor had little or no effect on entry by a large panel of hantaviruses. Viral interactions with host factors TIM-1, Axl or even Glut-1 cannot be excluded for the pathophysiology governing the haemorrhagic fever caused by other viruses, like New World Arenaviruses, Crimean-Congo haemorrhagic fever virus, or hantaviruses. It is a matter of further experimental research.</p></sec></sec><sec id="sec8"><title>Final remarks and future perspectives</title><p>Glucose and ascorbate homeostasis, the presence of Glut-1 on erythrocytes and the erythrocyte physiology
<sup>
<xref rid="ref50" ref-type="bibr">52</xref>
</sup> might play an important role in Filovirus disease, not excluding viral interactions with the erythrocyte membrane. The blood glucose concentration is maintained within narrow limits by an inter-play between tissue glucose uptake, hepatic glucose production and insulin production. Erythrocytes, because of their number in blood, perform an important buffering function of glucose and ascorbate/dehydroascorbate levels in plasma. Erythrocyte counts of frugivorous species have been shown lower than those reported for insectivorous bats.
<sup>
<xref rid="ref51" ref-type="bibr">53</xref>
</sup> In those species not able to synthesize ascorbate and expressing Glut-1 on erythrocytes virus interactions would lead to severe disturbance of the glucose and ascorbate levels in plasma, activation of hypoxia-inducible factors and haemolysis. Coagulation abnormalities and haemorrhages are a clinical feature of Ebola virus haemorrhagic fever. It should also be tested the possible importance of haemolysis and erythrocyte-virus interactions. As it is shown in an important paper
<sup>
<xref rid="ref52" ref-type="bibr">54</xref>
</sup> erythrocytes can regulate platelet reactivity directly through chemical signalling and adhesive erythrocyte-platelet interactions. Cell free haemoglobin induces platelet aggregation contributing to high risk of thrombotic complications. Adhesion of abnormal and/or stimulated erythrocytes to vascular endothelium can contribute to vasculature occlusions associated with thrombosis. Efficient blood coagulation requires sufficient pro-thrombotic surfaces, which are provided by cells that expose phosphatidylserine, which is normally in the cytoplasmic side of the membrane to separate this pro-coagulant surface from plasma coagulation factors. The questions are: Could virus-erythrocytes interactions induce the exposure of phosphatidylserine on the cell surface? Is the phosphatidylserine-enriched envelope of some haemorrhagic fever-causing virions involved in this pro-thrombotic process mediated by exposed phosphatidylserine?</p><p>As the filovirus glycoproteins could interact with Glut-1 or other functionally related protein, the influx of glucose into the cells is severely impaired. As a consequence, transient hyperglycemia and a marked oxidative stress coupled with the high levels of glucose in plasma would be established, and then promote the activation of NF&#x02013;&#x003ba;B transcription, exacerbating a pro-inflammatory response mediated by cytokines and chemokines, as described by Katherine Esposito et al.
<sup>
<xref rid="ref4" ref-type="bibr">4</xref>
</sup> On the other hand, the inability to synthesize ascorbate and the unavailability of ascorbate to entry into the cells through Glut-1 is an Achilles Heel when trying to counteract the oxidative stress. Additionally, there is another pathophysiological process to be mentioned: interactions with Glut-1 or other functionally related protein lead to an imbalance in the glucose homeostasis and the availability of glucose, not only for the erythrocytes, but also for CD8+ and CD4+ cells. These phenomena result in the bystander apoptosis of lymphocytes mediated by the lack of glucose, as described by Maclver et al.
<sup>
<xref rid="ref53" ref-type="bibr">55</xref>
</sup> Activated T cells have dramatically increased metabolic requirements to support their demands.
<sup>
<xref rid="ref54" ref-type="bibr">56</xref>
</sup> Therefore, activation of T cells causes a large increase in Glut-1 expression and surface localization, also promoting the Rab11b recycling of Glut-1 intracellular pools.
<sup>
<xref rid="ref53" ref-type="bibr">55</xref>
</sup> A work on the mechanisms and consequences of Ebolavirus-induced lymphocyte apoptosis concluded undefined that Ebola virus induces multiple pro-apoptotic stimuli.
<sup>
<xref rid="ref55" ref-type="bibr">57</xref>
</sup> As identified by Zhao and colleagues
<sup>
<xref rid="ref56" ref-type="bibr">58</xref>
</sup> in 2007 there is a glucose-initiated signaling pathway that leads to inhibition of GSK-3 and prevents cell death through stabilization of the anti-apoptotic BcI2 family protein McI. Normally targeted for proteasomal degradation by the ubiquitin E3 ligases, in highly glycolytic cells as are cancer cells and activated T cells, McI remains unphosphorylated and is not degraded, increasing the threshold for cell-death and maintaining cell survival. Conversely, when glucose uptake is limited, glycolytic flux decreases to a level that no longer sustains viability and pro-apoptotic signals promote cell death.
<sup>
<xref rid="ref53" ref-type="bibr">55</xref>
</sup>
</p><p>At a strictly cellular level, cell&#x02013;adhesion dependent membrane trafficking of a binding partner for the EBOV glycoprotein has been shown to be a determinant of viral entry
<sup>
<xref rid="ref57" ref-type="bibr">59</xref>
</sup> and attachment to adhesion substratum has been shown to induce the accumulation of glucose transporters and stimulate glucose metabolism in PC12 cells.
<sup>
<xref rid="ref58" ref-type="bibr">60</xref>
</sup> According to Dube and colleagues a membrane trafficking event translocates the unknown binding partner of the receptor binding region (RBR) of EBOV glycoprotein (GP) to the cell surface and they identified two adherent primate lymphocytic cell lines that bind viral glycoprotein RBR at their surface and supported GP-mediated entry and infection. Lymphocytes are normally described in literature as non-permissive for EBOV-GP mediated entry and infection,
<sup>
<xref rid="ref59" ref-type="bibr">61</xref>
</sup> and activation of lymphocytes could be the trigger that renders them susceptible. According to the present hypothesis, this binding partner related to lymphocyte activation may possibly be or be related to Glut-1.</p><p>This first clue about a link between EBOV species range, expression of Glut-1 on erythrocytes and inability to synthesize ascorbate in humans and non-human primates should be further analyzed. In contrast to primates, and according to a study by Cui et al., bats are perhaps in the process of large-scale loss of ascorbate biosynthesis ability,
<sup>
<xref rid="ref60" ref-type="bibr">62</xref>
</sup> and show varying degrees of lack of gluconolactone oxidase function. This evolutionary recent loss of the ability to synthesize ascorbate could account for differences in Glut-1 expression and ascorbate metabolism resulting in differences in filovirus pathophysiology between species. In another study the same authors showed that the fruit bat
<italic toggle="yes">Rousettus leschenaultii</italic> has retained the ability to synthesize ascorbate although at low levels compared with the mouse.
<sup>
<xref rid="ref61" ref-type="bibr">63</xref>
</sup> Olival et al. found serological evidence to both species Reston and Zaire of the genus Ebolavirus in
<italic toggle="yes">Rousettus leschenaultii</italic>, one of the fruit bats species considered to be reservoir of EBOV,
<sup>
<xref rid="ref62" ref-type="bibr">64</xref>
</sup> and Marburgvirus has even been isolated from
<italic toggle="yes">Rousettus aegyptiacus</italic>,
<sup>
<xref rid="ref63" ref-type="bibr">65</xref>
</sup> another Pteropodidae member. It is known that frugivorous and nectarivorous bats are able to ingest large quantities of sugar in a short time span while avoiding the potentially adverse side-effects of elevated blood glucose, which could be an important fact supporting the hypothesis that glucose and ascorbate metabolism account for the severity of the haemorrhagic fevers in primates and for the role of fruit bats as reservoir species maintaining low levels of filovirus replication. This ability to ingest large quantities of sugar in a short time span while avoiding the potentially adverse side-effects of elevated blood glucose has been related to the adaptive evolution in the glucose transporter 4 (Glut-4) gene in skeletal muscle
<sup>
<xref rid="ref64" ref-type="bibr">66</xref>
</sup> and also to high passive paracellular absorption of glucose in the gut of
<italic toggle="yes">Rousettus aegyptiacus</italic>.
<sup>
<xref rid="ref65" ref-type="bibr">67</xref>
</sup> The importance of Glut-4 and the active sodium-ascorbate co-transporters (SVCTs) and active sodium-dependent glucose cotransporters (SGLTs) in regard to Filovirus pathophysiology should be further investigated.</p><p>Regarding LHFV, the differences in glucose and ascorbate physiology could be an explanation of the absence of haemorrhagic manifestations of the illness in mice while primates and humans develop haemorrhagic fevers. If direct interactions of filoviral glycoproteins with Glut-1 could be demonstrated, it could partialy explain the differences in severity of the disease manifestations between Ebola and Lassa infections and others. It has been shown that the EBOV glycoprotein is the main determinant of cell cytotoxicity and injury.
<sup>
<xref rid="ref66" ref-type="bibr">68</xref>
</sup> It should be further researched which role plays the viral glycoprotein in cell cytotoxicity for LHFV and DENV. The differences in haemorrhagic fever prevalence and severity between EBOV, LHFV and DENV could be explained by the differences in the pools of cellular factors and receptors involved in virus activity. Direct interactions with Glut-1 could explain the direct incidence of the EBOV on the glucose and ascorbate transport and homeostasis, causing the transient hyperglycemia, cytokine storming and haemorrhagic features. On the other hand, TIM-1 and Axl are entry factors for LHFV only under specific circumstances: in other words, are only a dystroglycan-independent entry route. The concentration of phosphatidylserine displayed in the viral envelope influences virus binding via Axl, as is described in another important paper.
<sup>
<xref rid="ref67" ref-type="bibr">69</xref>
</sup> According to these authors, since functional &#x003b1;-dystroglycan is recognized by the viral envelope protein GP1 of LHFV, the exact ratio of LHFV GP1 to phosphatidylserine in the viral envelope appears critical for receptor use. When the presence of phosphatidylserine on the virion surface is qualitatively important in relation to the expression of GP1 in Lassa virus, the cellular entry of the virus through the interaction phosphatidylserine-Gas6-Axl or phosphatidylserine-TIM-1 would lead to the hypothesized metabolic disturbances, mediated by TIM-1 and/or Axl, probably via Glut-1. When Axl or TIM-1 are not an important receptor for LHFV entry and entry occurs via interaction of the viral GP1 with &#x003b1;-dystroglycan, the incidence of metabolic disorders and haemorrhagic manifestations would be lower.</p><p>For Dengue virus, when virus-host interactions mainly take place via viral glycoprotein-DC-SIGN interaction, the metabolic glucose and ascorbate disorders and haemorrhagic manifestations would be less important than in those cases in which viral interactions with host factors involve the interaction of the viral envelope with Axl and/or TIM-1. These different host factors that can interact with the viral envelope would explain the differences in pathophysiology: normal Dengue fever when DC-SIGN-viral glycoprotein interactions are predominant, or Dengue severe haemorrhagic fever when Axl and/or TIM-1 interact predominantly with the dengue virus envelope. The presence and importance of phosphatidylserine in the virus envelope could vary from virus to virus and from one virus type or strain (DENV-1, DENV-2, DENV-3, DENV-4, LV-1, LV-2, LFV-3, L V-4) to another. This should be matter of further research. It would be interesting to know which factors are governing the significant presence of phosphatidylserine on the virion envelope, and this considering the four haemorrhagic viruses: Ebola virus, Marburg virus, Lassa virus and Dengue virus.</p><p>Pathogenesis of viral haemorrhagic fevers is not yet well understood. The interaction of viruses with metabolism is a matter that will gain more attention in the next years. If direct interactions of filoviral glycoproteins with Glut-1 could be experimentally confirmed, it would even open up new opportunities to challenge Glut-1 transporters in cancer cells.</p></sec><sec sec-type="conclusions" id="sec9"><title>Conclusion</title><p>If some assumptions hypothesized in this opinion article were correct, regardless of other means of challenging the viruses, supportive care of haemorrhagic fevers almost in general could be significantly improved. It encompasses the use of insulin, ascorbate, glutathione (which participates, along with NADH, in the reduction of dehydroascorbate to ascorbate), maintaining constant and normal levels of glucose in plasma and general measures to counteract oxidative stress. Filoviruses originate from Africa, where almost all outbreaks have taken place, and a low-cost approach of the treatment would be advantageous for practical reasons.</p></sec></body><back><sec sec-type="data-availability" id="sec10"><title>Data availability</title><sec id="sec11"><title>Underlying data</title><p>No data are associated with this article.</p></sec></sec><ref-list><title>References</title><ref id="ref1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Aguirre</surname><given-names>R</given-names></name>
<name><surname>May</surname><given-names>JM</given-names></name>
</person-group>:
<article-title>Inflammation in the Vascular Bed: Importance of Vitamin C.</article-title>
<source>
<italic toggle="yes">Pharmacol. Ther.</italic>
</source>
<year>2008</year>;<volume>119</volume>(<issue>1</issue>):<fpage>96</fpage>&#x02013;<lpage>103</lpage>.
<pub-id pub-id-type="doi">10.1016/j.pharmthera.2008.05.002</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC2538426</pub-id>-->
<pub-id pub-id-type="pmid">18582947</pub-id>
</mixed-citation></ref><ref id="ref2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rao</surname><given-names>K</given-names></name>
<name><surname>Chouhan</surname><given-names>V</given-names></name>
<name><surname>Chen</surname><given-names>X</given-names></name>
<etal/>
</person-group>:
<article-title>Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men.</article-title>
<source>
<italic toggle="yes">Diabetes.</italic>
</source>
<year>1999</year>;<volume>48</volume>:<fpage>1156</fpage>&#x02013;<lpage>1161</lpage>.
<pub-id pub-id-type="doi">10.2337/diabetes.48.5.1156</pub-id>
<pub-id pub-id-type="pmid">10331423</pub-id>
</mixed-citation></ref><ref id="ref3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Iwasaki</surname><given-names>Y</given-names></name>
<name><surname>Kambayashi</surname><given-names>M</given-names></name>
<name><surname>Asai</surname><given-names>M</given-names></name>
<etal/>
</person-group>:
<article-title>High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocyte sin vitro.</article-title>
<source>
<italic toggle="yes">J. Diabetes Complicat.</italic>
</source>
<year>2007</year>;<volume>21</volume>(<issue>1</issue>):<fpage>56</fpage>&#x02013;<lpage>62</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jdiacomp.2006.02.001</pub-id>
<pub-id pub-id-type="pmid">17189875</pub-id>
</mixed-citation></ref><ref id="ref4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Esposito</surname><given-names>K</given-names></name>
<name><surname>Nappo</surname><given-names>F</given-names></name>
<name><surname>Marfella</surname><given-names>R</given-names></name>
<etal/>
</person-group>:
<article-title>Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.</article-title>
<source>
<italic toggle="yes">Circulation.</italic>
</source>
<year>2002 Oct 15</year>;<volume>106</volume>(<issue>16</issue>):<fpage>2067</fpage>&#x02013;<lpage>2072</lpage>.
<pub-id pub-id-type="doi">10.1161/01.cir.0000034509.14906.ae</pub-id>
<pub-id pub-id-type="pmid">12379575</pub-id>
</mixed-citation></ref><ref id="ref5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hu</surname><given-names>R</given-names></name>
<name><surname>Xia</surname><given-names>CQ</given-names></name>
<name><surname>Butfiloski</surname><given-names>E</given-names></name>
<etal/>
</person-group>:
<article-title>2018. Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection.</article-title>
<source>
<italic toggle="yes">Clin. Immunol.</italic>
</source>
<year>2018 Oct</year>;<volume>195</volume>:<fpage>139</fpage>&#x02013;<lpage>148</lpage>.
<pub-id pub-id-type="doi">10.1016/j.clim.2018.06.003</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC6119493</pub-id>-->
<pub-id pub-id-type="pmid">29894743</pub-id>
</mixed-citation></ref><ref id="ref6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Geisbert</surname><given-names>TW</given-names></name>
<name><surname>Young</surname><given-names>HA</given-names></name>
<name><surname>Jahrling</surname><given-names>PB</given-names></name>
<etal/>
</person-group>:
<article-title>Pathogenesis of Ebola Haemorrhagic fever in primate models. Evidence that haemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.</article-title>
<source>
<italic toggle="yes">Am. J. Pathol.</italic>
</source>
<year>2003</year>;<volume>163</volume>(<issue>6</issue>):<fpage>2371</fpage>&#x02013;<lpage>2382</lpage>.
<pub-id pub-id-type="doi">10.1016/S0002-9440(10)63592-4</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC1892396</pub-id>-->
<pub-id pub-id-type="pmid">14633609</pub-id>
</mixed-citation></ref><ref id="ref7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Heller</surname><given-names>R</given-names></name>
<name><surname>M&#x000fc;nscher-Paulig</surname><given-names>F</given-names></name>
<name><surname>Gr&#x000e4;bner</surname><given-names>R</given-names></name>
<etal/>
</person-group>:
<article-title>L-ascorbic acid potentiates nitric oxide synthesis in endothelial cells.</article-title>
<source>
<italic toggle="yes">J. Biol. Chem.</italic>
</source>
<year>1999</year>;<volume>274</volume>(<issue>12</issue>):<fpage>8254</fpage>&#x02013;<lpage>8260</lpage>.
<pub-id pub-id-type="doi">10.1074/jbc.274.12.8254</pub-id>
<pub-id pub-id-type="pmid">10075731</pub-id>
</mixed-citation></ref><ref id="ref8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Utoguchi</surname><given-names>N</given-names></name>
<name><surname>Ikeda</surname><given-names>K</given-names></name>
<name><surname>Saeki</surname><given-names>K</given-names></name>
<etal/>
</person-group>:
<article-title>Ascorbic acid stimulates barrier function of cultured endothelial cell monolayer.</article-title>
<source>
<italic toggle="yes">J. Cell. Physiol.</italic>
</source>
<year>1995</year>;<volume>163</volume>(<issue>2</issue>):<fpage>393</fpage>&#x02013;<lpage>399</lpage>.
<pub-id pub-id-type="doi">10.1002/jcp.1041630219</pub-id>
<pub-id pub-id-type="pmid">7706381</pub-id>
</mixed-citation></ref><ref id="ref9"><label>9</label><mixed-citation publication-type="journal">
<collab>Symmers WStC</collab>:
<article-title>Thrombotic microangiopathic haemolytic anaemia (thrombocytic microangiopathy).</article-title>
<source>
<italic toggle="yes">Br. Med. J.</italic>
</source>
<year>1952</year>;<volume>2</volume>:<fpage>897</fpage>&#x02013;<lpage>903</lpage>.
<pub-id pub-id-type="doi">10.1136/bmj.2.4790.897</pub-id>
<pub-id pub-id-type="pmid">12978378</pub-id>
</mixed-citation></ref><ref id="ref10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Feldmann</surname><given-names>H</given-names></name>
<name><surname>Geisbert</surname><given-names>TW</given-names></name>
</person-group>:
<article-title>Ebola haemorrhagic fever.</article-title>
<source>
<italic toggle="yes">Lancet.</italic>
</source>
<year>2011</year>;<volume>377</volume>(<issue>9768</issue>):<fpage>849</fpage>&#x02013;<lpage>862</lpage>.
<pub-id pub-id-type="doi">10.1016/S0140-6736(10)60667-8</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC3406178</pub-id>-->
<pub-id pub-id-type="pmid">21084112</pub-id>
</mixed-citation></ref><ref id="ref11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mahanty</surname><given-names>S</given-names></name>
<name><surname>Bray</surname><given-names>M</given-names></name>
</person-group>:
<article-title>Pathogenesis of Filoviral haemorrhagic fevers.</article-title>
<source>
<italic toggle="yes">Lancet Infect. Dis.</italic>
</source>
<year>2004</year>;<volume>4</volume>(<issue>8</issue>):<fpage>487</fpage>&#x02013;<lpage>498</lpage>.
<pub-id pub-id-type="doi">10.1016/S1473-3099(04)01103-X</pub-id>
<pub-id pub-id-type="pmid">15288821</pub-id>
</mixed-citation></ref><ref id="ref12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kortepeter</surname><given-names>MG</given-names></name>
<name><surname>Bausch</surname><given-names>DG</given-names></name>
<name><surname>Bray</surname><given-names>M</given-names></name>
</person-group>:
<article-title>Basic Clinical and Laboratory Features of Filoviral Haemorrhagic Fever.</article-title>
<source>
<italic toggle="yes">J. Infect. Dis.</italic>
</source>
<year>2011</year>;<volume>204</volume>:<fpage>S810</fpage>&#x02013;<lpage>S816</lpage>.
<pub-id pub-id-type="doi">10.1093/infdis/jir299</pub-id>
<pub-id pub-id-type="pmid">21987756</pub-id>
</mixed-citation></ref><ref id="ref13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Malvy</surname><given-names>D</given-names></name>
<name><surname>McElroy</surname><given-names>AK</given-names></name>
<name><surname>Clerck</surname><given-names>H</given-names><prefix>de</prefix></name>
<etal/>
</person-group>:
<article-title>Ebola virus disease.</article-title>
<source>
<italic toggle="yes">Lancet.</italic>
</source>
<year>2019</year>;<volume>393</volume>(<issue>10174</issue>):<fpage>936</fpage>&#x02013;<lpage>948</lpage>. Epub 2019 Feb 15. Erratum in: Lancet. 2019 May 18;393(10185):2038.
<pub-id pub-id-type="doi">10.1016/S0140-6736(18)33132-5</pub-id>
<pub-id pub-id-type="pmid">30777297</pub-id>
</mixed-citation></ref><ref id="ref14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nicastri</surname><given-names>E</given-names></name>
<name><surname>Kobinger</surname><given-names>G</given-names></name>
<name><surname>Vairo</surname><given-names>F</given-names></name>
<etal/>
</person-group>:
<article-title>Ebola Virus Disease: Epidemiology, Clinical Features, Management, and Prevention.</article-title>
<source>
<italic toggle="yes">Infect. Dis. Clin. N. Am.</italic>
</source>
<year>2019</year>;<volume>33</volume>(<issue>4</issue>):<fpage>953</fpage>&#x02013;<lpage>976</lpage>.
<pub-id pub-id-type="doi">10.1016/j.idc.2019.08.005</pub-id>
<pub-id pub-id-type="pmid">31668200</pub-id>
</mixed-citation></ref><ref id="ref15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mueckler</surname><given-names>M</given-names></name>
<name><surname>Caruso</surname><given-names>C</given-names></name>
<name><surname>Baldwin</surname><given-names>SA</given-names></name>
<etal/>
</person-group>:
<article-title>Sequence and structure of a human glucose transporter.</article-title>
<source>
<italic toggle="yes">Science.</italic>
</source>
<year>1985</year>;<volume>229</volume>(<issue>4717</issue>):<fpage>941</fpage>&#x02013;<lpage>945</lpage>.
<pub-id pub-id-type="doi">10.1126/science.3839598</pub-id>
<pub-id pub-id-type="pmid">3839598</pub-id>
</mixed-citation></ref><ref id="ref16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Olson</surname><given-names>AL</given-names></name>
<name><surname>Pessin</surname><given-names>JE</given-names></name>
</person-group>:
<article-title>Structure, function, and regulation of the mammalian facilitative glucose transporter gene family.</article-title>
<source>
<italic toggle="yes">Annu. Rev. Nutr.</italic>
</source>
<year>1996</year>;<volume>16</volume>:<fpage>235</fpage>&#x02013;<lpage>256</lpage>.
<pub-id pub-id-type="doi">10.1146/annurev.nu.16.070196.001315</pub-id>
<pub-id pub-id-type="pmid">8839927</pub-id>
</mixed-citation></ref><ref id="ref17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Montel-Hagen</surname><given-names>A</given-names></name>
<name><surname>Kinet</surname><given-names>S</given-names></name>
<name><surname>Manel</surname><given-names>N</given-names></name>
<etal/>
</person-group>:
<article-title>Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C.</article-title>
<source>
<italic toggle="yes">Cell.</italic>
</source>
<year>2008</year>;<volume>132</volume>(<issue>6</issue>):<fpage>1039</fpage>&#x02013;<lpage>1048</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2008.01.042</pub-id>
<pub-id pub-id-type="pmid">18358815</pub-id>
</mixed-citation></ref><ref id="ref18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Montel-Hagen</surname><given-names>A</given-names></name>
<name><surname>Sitbon</surname><given-names>M</given-names></name>
<name><surname>Taylor</surname><given-names>N</given-names></name>
</person-group>:
<article-title>Erythroid glucose transporters.</article-title>
<source>
<italic toggle="yes">Curr. Opin. Hematol.</italic>
</source>
<year>2009</year>;<volume>16</volume>(<issue>3</issue>):<fpage>165</fpage>&#x02013;<lpage>172</lpage>.
<pub-id pub-id-type="doi">10.1097/MOH.0b013e328329905c</pub-id>
<pub-id pub-id-type="pmid">19346941</pub-id>
</mixed-citation></ref><ref id="ref19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Leroy</surname><given-names>E</given-names></name>
<name><surname>Kumulungui</surname><given-names>B</given-names></name>
<name><surname>Pourrut</surname><given-names>X</given-names></name>
<etal/>
</person-group>:
<article-title>Fruit bats as reservoirs of Ebola virus.</article-title>
<source>
<italic toggle="yes">Nature.</italic>
</source>
<year>2005</year>;<volume>438</volume>(<issue>2005</issue>):<fpage>575</fpage>&#x02013;<lpage>576</lpage>.
<pub-id pub-id-type="doi">10.1038/438575a</pub-id>
<pub-id pub-id-type="pmid">16319873</pub-id>
</mixed-citation></ref><ref id="ref20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Weingartl</surname><given-names>HM</given-names></name>
<name><surname>Embury-Hyatt</surname><given-names>C</given-names></name>
<name><surname>Nfon</surname><given-names>C</given-names></name>
<etal/>
</person-group>:
<article-title>Transmission of Ebola virus from pigs to non-human primates.</article-title>
<source>
<italic toggle="yes">Sci. Rep.</italic>
</source>
<year>2012</year>;<volume>2</volume>:<fpage>811</fpage>.
<pub-id pub-id-type="doi">10.1038/srep00811</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC3498927</pub-id>-->
<pub-id pub-id-type="pmid">23155478</pub-id>
</mixed-citation></ref><ref id="ref21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kobinger</surname><given-names>GP</given-names></name>
<name><surname>Leung</surname><given-names>A</given-names></name>
<name><surname>Neufeld</surname><given-names>J</given-names></name>
<etal/>
</person-group>:
<article-title>Replication, Pathogenicity, Shedding, and Transmission of Zaire ebolavirus in Pigs.</article-title>
<source>
<italic toggle="yes">J. Infect. Dis.</italic>
</source>
<year>2011</year>;<volume>204</volume>:<fpage>179</fpage>&#x02013;<lpage>181</lpage>.<pub-id pub-id-type="pmid">21571727</pub-id>
</mixed-citation></ref><ref id="ref22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bray</surname><given-names>M</given-names></name>
</person-group>:
<article-title>Mahanty S (2003) Ebola Hemorrhagic Fever and Septic Shock.</article-title>
<source>
<italic toggle="yes">J. Infect. Dis.</italic>
</source>
<year>2003</year>;<volume>188</volume>:<fpage>1613</fpage>&#x02013;<lpage>1617</lpage>.
<pub-id pub-id-type="doi">10.1086/379727</pub-id>
<pub-id pub-id-type="pmid">14639530</pub-id>
</mixed-citation></ref><ref id="ref23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yonezawa</surname><given-names>A</given-names></name>
<name><surname>Cavrois</surname><given-names>M</given-names></name>
<name><surname>Greene</surname><given-names>WC</given-names></name>
</person-group>:
<article-title>Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type-1 virions: involvement of cytoskeletal proteins and enhancement by Tumor necrosis factor alpha.</article-title>
<source>
<italic toggle="yes">J. Virol.</italic>
</source>
<year>2005</year>;<volume>79</volume>(<issue>2</issue>):<fpage>918</fpage>&#x02013;<lpage>926</lpage>.
<pub-id pub-id-type="doi">10.1128/JVI.79.2.918-926.2005</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC538559</pub-id>-->
<pub-id pub-id-type="pmid">15613320</pub-id>
</mixed-citation></ref><ref id="ref24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Manel</surname><given-names>N</given-names></name>
<name><surname>Kim</surname><given-names>FJ</given-names></name>
<name><surname>Kinet</surname><given-names>S</given-names></name>
<etal/>
</person-group>:
<article-title>The ubiquitous glucose transporter Glut-1 is a receptor for HTLV.</article-title>
<source>
<italic toggle="yes">Cell.</italic>
</source>
<year>2003</year>;<volume>115</volume>(<issue>4</issue>):<fpage>449</fpage>&#x02013;<lpage>459</lpage>.
<pub-id pub-id-type="doi">10.1016/S0092-8674(03)00881-X</pub-id>
<pub-id pub-id-type="pmid">14622599</pub-id>
</mixed-citation></ref><ref id="ref25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Salas-Burgos</surname><given-names>A</given-names></name>
<name><surname>Iserovich</surname><given-names>P</given-names></name>
<name><surname>Zu&#x000f1;iga</surname><given-names>F</given-names></name>
<etal/>
</person-group>:
<article-title>Predicting the Three-dimensional structure of the human facilitative glucose transporter Glut1 by a novel evolutionary homology strategy: Insights on the molecular mechanism of substrate Migration, and binding sites for glucose and inhibitory molecules.</article-title>
<source>
<italic toggle="yes">Biophys. J.</italic>
</source>
<year>2004 Nov</year>;<volume>87</volume>(<issue>5</issue>):<fpage>2990</fpage>&#x02013;<lpage>2999</lpage>.
<pub-id pub-id-type="doi">10.1529/biophysj.104.047886</pub-id>
<pub-id pub-id-type="pmid">15326030</pub-id>
</mixed-citation></ref><ref id="ref26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Saeed</surname><given-names>MF</given-names></name>
<name><surname>Kolokoltsov</surname><given-names>AA</given-names></name>
<name><surname>Freiberg</surname><given-names>AN</given-names></name>
<etal/>
</person-group>:
<article-title>Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus.</article-title>
<source>
<italic toggle="yes">PLoS Pathog.</italic>
</source>
<year>2008 Aug 29</year>;<volume>4</volume>(<issue>8</issue>): e1000141.
<pub-id pub-id-type="doi">10.1371/journal.ppat.1000141</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC2516934</pub-id>-->
<pub-id pub-id-type="pmid">18769720</pub-id>
</mixed-citation></ref><ref id="ref27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wieman</surname><given-names>HL</given-names></name>
<name><surname>Wofford</surname><given-names>JA</given-names></name>
<name><surname>Rathmell</surname><given-names>JC</given-names></name>
</person-group>:
<article-title>Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking.</article-title>
<source>
<italic toggle="yes">Mol Biol Cell.</italic>
</source>
<year>2007 Apr</year>;<volume>18</volume>(<issue>4</issue>):<fpage>1437</fpage>&#x02013;<lpage>1446</lpage>.
<pub-id pub-id-type="doi">10.1091/mbc.e06-07-0593</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC1838986</pub-id>-->
<pub-id pub-id-type="pmid">17301289</pub-id>
</mixed-citation></ref><ref id="ref28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Carette</surname><given-names>JE</given-names></name>
<name><surname>Raaben</surname><given-names>M</given-names></name>
<name><surname>Wong</surname><given-names>AC</given-names></name>
<etal/>
</person-group>:
<article-title>Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.</article-title>
<source>
<italic toggle="yes">Nature.</italic>
</source>
<year>2011</year>;<volume>477</volume>(<issue>7364</issue>):<fpage>340</fpage>&#x02013;<lpage>343</lpage>.
<pub-id pub-id-type="doi">10.1038/nature10348</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC3175325</pub-id>-->
<pub-id pub-id-type="pmid">21866103</pub-id>
</mixed-citation></ref><ref id="ref29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Brindley</surname><given-names>MA</given-names></name>
<name><surname>Hunt</surname><given-names>CL</given-names></name>
<name><surname>Kondratowicz</surname><given-names>AS</given-names></name>
<etal/>
</person-group>:
<article-title>Tyrosine kinase receptor Axl enhances entry of Zaire Ebolavirus without direct interaction with the viral glycoprotein.</article-title>
<source>
<italic toggle="yes">Virology.</italic>
</source>
<year>2011</year>;<volume>415</volume>(<issue>2</issue>):<fpage>83</fpage>&#x02013;<lpage>94</lpage>.
<pub-id pub-id-type="doi">10.1016/j.virol.2011.04.002</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC3107944</pub-id>-->
<pub-id pub-id-type="pmid">21529875</pub-id>
</mixed-citation></ref><ref id="ref30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kondratowicz</surname><given-names>AS</given-names></name>
<name><surname>Lennemann</surname><given-names>NJ</given-names></name>
<name><surname>Sinn</surname><given-names>PL</given-names></name>
<etal/>
</person-group>:
<article-title>T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus.</article-title>
<source>
<italic toggle="yes">Proc. Natl. Acad. Sci. U. S. A.</italic>
</source>
<year>2011</year>;<volume>108</volume>(<issue>20</issue>):<fpage>8426</fpage>&#x02013;<lpage>8431</lpage>.
<pub-id pub-id-type="doi">10.73/pnas.1019030108</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC3100998</pub-id>-->
<pub-id pub-id-type="pmid">21536871</pub-id>
</mixed-citation></ref><ref id="ref31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Brunton</surname><given-names>B</given-names></name>
<name><surname>Rogers</surname><given-names>K</given-names></name>
<name><surname>Phillips</surname><given-names>EK</given-names></name>
<etal/>
</person-group>:
<article-title>TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis.</article-title>
<source>
<italic toggle="yes">PLoS Negl. Trop. Dis.</italic>
</source>
<year>2019</year>;<volume>13</volume>(<issue>6</issue>):<fpage>e0006983</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pntd.0006983</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC6615641</pub-id>-->
<pub-id pub-id-type="pmid">31242184</pub-id>
</mixed-citation></ref><ref id="ref32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Brouillette</surname><given-names>RB</given-names></name>
<name><surname>Phillips</surname><given-names>EK</given-names></name>
<name><surname>Patel</surname><given-names>R</given-names></name>
<etal/>
</person-group>:
<article-title>TIM-1 mediates dystroglycan-independent entry of Lassa virus.</article-title>
<source>
<italic toggle="yes">J. Virol.</italic>
</source>
<year>2018</year>;<volume>92</volume>(<issue>16</issue>):<fpage>e00093</fpage>&#x02013;<lpage>e00018</lpage>.
<pub-id pub-id-type="doi">10.1128/JVI.00093-18</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC6069209</pub-id>-->
<pub-id pub-id-type="pmid">29875238</pub-id>
</mixed-citation></ref><ref id="ref33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Moller-Tank</surname><given-names>S</given-names></name>
<name><surname>Kondratowicz</surname><given-names>AS</given-names></name>
<name><surname>Davey</surname><given-names>RA</given-names></name>
<etal/>
</person-group>:
<article-title>Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry.</article-title>
<source>
<italic toggle="yes">J. Virol.</italic>
</source>
<year>2013</year>;<volume>87</volume>:<fpage>8327</fpage>&#x02013;<lpage>8341</lpage>.
<pub-id pub-id-type="doi">10.1128/JVI.01025-13</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC3719829</pub-id>-->
<pub-id pub-id-type="pmid">23698310</pub-id>
</mixed-citation></ref><ref id="ref34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Moller-Tank</surname><given-names>S</given-names></name>
<name><surname>Albritton</surname><given-names>LM</given-names></name>
<name><surname>Rennert</surname><given-names>PD</given-names></name>
<etal/>
</person-group>:
<article-title>Characterizing functional domains for TIM-mediated enveloped virus entry.</article-title>
<source>
<italic toggle="yes">J. Virol.</italic>
</source>
<year>2014</year>;<volume>88</volume>:<fpage>6702</fpage>&#x02013;<lpage>6713</lpage>.
<pub-id pub-id-type="doi">10.1128/JVI.00300-14</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC4054341</pub-id>-->
<pub-id pub-id-type="pmid">24696470</pub-id>
</mixed-citation></ref><ref id="ref35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kobayashi</surname><given-names>N</given-names></name>
<name><surname>Karisola</surname><given-names>P</given-names></name>
<name><surname>Pena-Cruz</surname><given-names>V</given-names></name>
<etal/>
</person-group>:
<article-title>TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.</article-title>
<source>
<italic toggle="yes">Immunity.</italic>
</source>
<year>2007</year>;<volume>27</volume>:<fpage>927</fpage>&#x02013;<lpage>940</lpage>.
<pub-id pub-id-type="doi">10.1016/j.immuni.2007.11.011</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC2757006</pub-id>-->
<pub-id pub-id-type="pmid">18082433</pub-id>
</mixed-citation></ref><ref id="ref36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Miyanishi</surname><given-names>M</given-names></name>
<name><surname>Tada</surname><given-names>K</given-names></name>
<name><surname>Koike</surname><given-names>M</given-names></name>
<etal/>
</person-group>:
<article-title>Identification of Tim4 as a phosphatidylserine receptor.</article-title>
<source>
<italic toggle="yes">Nature.</italic>
</source>
<year>2007</year>;<volume>450</volume>:<fpage>435</fpage>&#x02013;<lpage>439</lpage>.
<pub-id pub-id-type="doi">10.1038/nature06307</pub-id>
<pub-id pub-id-type="pmid">17960135</pub-id>
</mixed-citation></ref><ref id="ref37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jemielity</surname><given-names>S</given-names></name>
<name><surname>Wang</surname><given-names>JJ</given-names></name>
<name><surname>Chan</surname><given-names>YK</given-names></name>
<etal/>
</person-group>:
<article-title>TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine.</article-title>
<source>
<italic toggle="yes">PLoS Pathog.</italic>
</source>
<year>2013</year>;<volume>9</volume>:<fpage>e1003232</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.ppat.1003232</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC3610696</pub-id>-->
<pub-id pub-id-type="pmid">23555248</pub-id>
</mixed-citation></ref><ref id="ref38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ichimura</surname><given-names>T</given-names></name>
<name><surname>Asseldonk</surname><given-names>EJ</given-names></name>
<name><surname>Humphreys</surname><given-names>BD</given-names></name>
<etal/>
</person-group>:
<article-title>Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.</article-title>
<source>
<italic toggle="yes">J. Clin. Invest.</italic>
</source>
<year>2008</year>;<volume>118</volume>:<fpage>1657</fpage>&#x02013;<lpage>1668</lpage>.
<pub-id pub-id-type="doi">10.1172/JCI34487</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC2293335</pub-id>-->
<pub-id pub-id-type="pmid">18414680</pub-id>
</mixed-citation></ref><ref id="ref39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Stitt</surname><given-names>TN</given-names></name>
<name><surname>Conn</surname><given-names>G</given-names></name>
<name><surname>Gore</surname><given-names>M</given-names></name>
<etal/>
</person-group>:
<article-title>The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases.</article-title>
<source>
<italic toggle="yes">Cell.</italic>
</source>
<year>1995</year>;<volume>80</volume>:<fpage>661</fpage>&#x02013;<lpage>670</lpage>.
<pub-id pub-id-type="doi">10.1016/0092-8674(95)90520-0</pub-id>
<pub-id pub-id-type="pmid">7867073</pub-id>
</mixed-citation></ref><ref id="ref40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Godowski</surname><given-names>PJ</given-names></name>
<name><surname>Mark</surname><given-names>MR</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
<etal/>
</person-group>:
<article-title>Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3.</article-title>
<source>
<italic toggle="yes">Cell.</italic>
</source>
<year>1995</year>;<volume>82</volume>:<fpage>355</fpage>&#x02013;<lpage>358</lpage>.
<pub-id pub-id-type="doi">10.1016/0092-8674(95)90424-7</pub-id>
<pub-id pub-id-type="pmid">7634325</pub-id>
</mixed-citation></ref><ref id="ref41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nagata</surname><given-names>K</given-names></name>
<name><surname>Ohashi</surname><given-names>K</given-names></name>
<name><surname>Nakano</surname><given-names>T</given-names></name>
<etal/>
</person-group>:
<article-title>Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases.</article-title>
<source>
<italic toggle="yes">J. Biol. Chem.</italic>
</source>
<year>1996</year>;<volume>271</volume>:<fpage>30022</fpage>&#x02013;<lpage>30027</lpage>.
<pub-id pub-id-type="doi">10.1074/jbc.271.47.30022</pub-id>
<pub-id pub-id-type="pmid">8939948</pub-id>
</mixed-citation></ref><ref id="ref42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Meertens</surname><given-names>L</given-names></name>
<name><surname>Carnec</surname><given-names>X</given-names></name>
<name><surname>Lecoin</surname><given-names>MP</given-names></name>
<etal/>
</person-group>:
<article-title>The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry.</article-title>
<source>
<italic toggle="yes">Cell Host Microbe.</italic>
</source>
<year>2012</year>;<volume>12</volume>(<issue>4</issue>):<fpage>544</fpage>&#x02013;<lpage>557</lpage>.
<pub-id pub-id-type="doi">10.1016/j.chom.2012.08.009</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC3572209</pub-id>-->
<pub-id pub-id-type="pmid">23084921</pub-id>
</mixed-citation></ref><ref id="ref43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>MJ</given-names></name>
<name><surname>Yun</surname><given-names>SJ</given-names></name>
<name><surname>Lee</surname><given-names>B</given-names></name>
<etal/>
</person-group>:
<article-title>Association of TIM-3 expression with glucose metabolism in Jurkat T cells.</article-title>
<source>
<italic toggle="yes">BMC Immunol.</italic>
</source>
<year>2020</year>;<volume>21</volume>:<fpage>48</fpage>.
<pub-id pub-id-type="doi">10.1186/s12865-020-00377-6</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC7441550</pub-id>-->
<pub-id pub-id-type="pmid">32819283</pub-id>
</mixed-citation></ref><ref id="ref44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Umetsu</surname><given-names>SE</given-names></name>
<name><surname>Lee</surname><given-names>WL</given-names></name>
<name><surname>McIntire</surname><given-names>JJ</given-names></name>
<etal/>
</person-group>:
<article-title>TIM-1 induces T cell activation and inhibits the development of peripheral tolerance.</article-title>
<source>
<italic toggle="yes">Nat. Immunol.</italic>
</source>
<year>2005</year>;<volume>6</volume>(<issue>5</issue>):<fpage>447</fpage>&#x02013;<lpage>454</lpage>.
<pub-id pub-id-type="doi">10.1038/ni1186</pub-id>
<pub-id pub-id-type="pmid">15793575</pub-id>
</mixed-citation></ref><ref id="ref45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>C</given-names></name>
<name><surname>Anderson</surname><given-names>AC</given-names></name>
<name><surname>Schubart</surname><given-names>A</given-names></name>
<etal/>
</person-group>:
<article-title>The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.</article-title>
<source>
<italic toggle="yes">Nat. Immunol.</italic>
</source>
<year>2005</year>;<volume>6</volume>(<issue>12</issue>):<fpage>1245</fpage>&#x02013;<lpage>1252</lpage>.
<pub-id pub-id-type="doi">10.1038/ni1271</pub-id>
<pub-id pub-id-type="pmid">16286920</pub-id>
</mixed-citation></ref><ref id="ref46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rhein</surname><given-names>BA</given-names></name>
<name><surname>Brouillette</surname><given-names>RB</given-names></name>
<name><surname>Schaack</surname><given-names>GA</given-names></name>
<etal/>
</person-group>:
<article-title>Characterization of Human and Murine T-Cell Immunoglobulin Mucin Domain 4 (TIM-4) IgV Domain Residues Critical for Ebola Virus Entry.</article-title>
<source>
<italic toggle="yes">J. Virol.</italic>
</source>
<year>2016</year>;<volume>90</volume>:<fpage>6097</fpage>&#x02013;<lpage>6111</lpage>.
<pub-id pub-id-type="doi">10.1128/JVI.00100-16</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC4907230</pub-id>-->
<pub-id pub-id-type="pmid">27122575</pub-id>
</mixed-citation></ref><ref id="ref47"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Loureiro</surname><given-names>ME</given-names></name>
<name><surname>D&#x02019;Antuono</surname><given-names>A</given-names></name>
<name><surname>L&#x000f3;pez</surname><given-names>N</given-names></name>
</person-group>:
<article-title>Virus
<sup>-</sup>Host Interactions Involved in Lassa Virus Entry and Genome Replication.</article-title>
<source>
<italic toggle="yes">Pathogens.</italic>
</source>
<year>2019</year>;<volume>8</volume>(<issue>1</issue>):<fpage>17</fpage>.
<pub-id pub-id-type="doi">10.3390/pathogens8010017</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC6470645</pub-id>-->
<pub-id pub-id-type="pmid">30699976</pub-id>
</mixed-citation></ref><ref id="ref48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cavet</surname><given-names>ME</given-names></name>
<name><surname>Smolock</surname><given-names>EM</given-names></name>
<name><surname>Ozturk</surname><given-names>OH</given-names></name>
<etal/>
</person-group>:
<article-title>Gas6 - Axl receptor signaling is regulated by glucose in vascular smooth muscle cells.</article-title>
<source>
<italic toggle="yes">Arterioscler. Thromb. Vasc. Biol.</italic>
</source>
<year>2008</year>;<volume>28</volume>(<issue>5</issue>):<fpage>886</fpage>&#x02013;<lpage>891</lpage>.
<pub-id pub-id-type="doi">10.1161/ATVBAHA.108.162693</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC2731942</pub-id>-->
<pub-id pub-id-type="pmid">18292389</pub-id>
</mixed-citation></ref><ref id="ref49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Strong</surname><given-names>JE</given-names></name>
<name><surname>Wong</surname><given-names>G</given-names></name>
<name><surname>Jones</surname><given-names>SE</given-names></name>
<etal/>
</person-group>:
<article-title>Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.</article-title>
<source>
<italic toggle="yes">Proc. Natl. Acad. Sci. U. S. A.</italic>
</source>
<year>2008</year>;<volume>105</volume>(<issue>46</issue>):<fpage>17982</fpage>&#x02013;<lpage>17987</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.0809698105</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC2577702</pub-id>-->
<pub-id pub-id-type="pmid">18981410</pub-id>
</mixed-citation></ref><ref id="ref68"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mackow</surname><given-names>ER</given-names></name>
<name><surname>Gavrilovskaya</surname><given-names>IN</given-names></name>
</person-group>:
<article-title>Cellular receptors and hantavirus pathogenesis.</article-title>
<source>
<italic toggle="yes">Curr Top Microbiol Immunol.</italic>
</source>
<year>2001</year>;<volume>256</volume>:<fpage>91</fpage>&#x02013;<lpage>115</lpage>.
<pub-id pub-id-type="doi">10.1007/978-3-642-56753-7_6</pub-id>
<pub-id pub-id-type="pmid">11217408</pub-id>
</mixed-citation></ref><ref id="ref69"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dieterle</surname><given-names>ME</given-names></name>
<name><surname>Sol&#x000e0;-Riera</surname><given-names>C</given-names></name>
<name><surname>Ye</surname><given-names>C</given-names></name>
<etal/>
</person-group>:
<article-title>Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cells.</article-title>
<source>
<italic toggle="yes">Elife.</italic>
</source>
<year>2021</year>Jul;<volume>10</volume>(<issue>10</issue>): e69708.
<pub-id pub-id-type="doi">10.7554/eLife.69708</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC8263056</pub-id>-->
<pub-id pub-id-type="pmid">34232859</pub-id>
</mixed-citation></ref><ref id="ref50"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>May</surname><given-names>JM</given-names></name>
</person-group>:
<article-title>Ascorbate function and metabolism in the human erythrocyte.</article-title>
<source>
<italic toggle="yes">Front Biosci.</italic>
</source>
<year>1998</year>;<volume>2</volume>:<fpage>D1</fpage>&#x02013;<lpage>D10</lpage>.</mixed-citation></ref><ref id="ref51"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Craik</surname><given-names>JD</given-names></name>
<name><surname>Markovich</surname><given-names>D</given-names></name>
</person-group>:
<article-title>Rapid GLUT-1 mediated glucose transport in erythrocytes from the grey-headed fruit bat (Pteropus poliocephalus).</article-title>
<source>
<italic toggle="yes">Comp. Biochem. Physiol. A Mol. Integr. Physiol.</italic>
</source>
<year>2000</year>;<volume>126</volume>(<issue>1</issue>):<fpage>45</fpage>&#x02013;<lpage>55</lpage>.
<pub-id pub-id-type="doi">10.1016/S1095-6433(00)00177-X</pub-id>
<pub-id pub-id-type="pmid">10908851</pub-id>
</mixed-citation></ref><ref id="ref52"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Litvinov</surname><given-names>RI</given-names></name>
<name><surname>Weisel</surname><given-names>JW</given-names></name>
</person-group>:
<article-title>Role of red blood cells in haemostasis and thrombosis.</article-title>
<source>
<italic toggle="yes">ISBT Sci. Ser.</italic>
</source>
<year>2017 Feb</year>;<volume>12</volume>(<issue>1</issue>):<fpage>176</fpage>&#x02013;<lpage>183</lpage>.
<pub-id pub-id-type="doi">10.1111/voxs.12331</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC5404239</pub-id>-->
<pub-id pub-id-type="pmid">28458720</pub-id>
</mixed-citation></ref><ref id="ref53"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Maclver</surname><given-names>NJ</given-names></name>
<name><surname>Jacvobs</surname><given-names>SR</given-names></name>
<name><surname>Wiemann</surname><given-names>HL</given-names></name>
<etal/>
</person-group>:
<article-title>Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival.</article-title>
<source>
<italic toggle="yes">J. Leukoc. Biol.</italic>
</source>
<year>2008</year>;<volume>84</volume>:<fpage>949</fpage>&#x02013;<lpage>957</lpage>.
<pub-id pub-id-type="doi">10.1189/jlb.0108024</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC2638731</pub-id>-->
<pub-id pub-id-type="pmid">18577716</pub-id>
</mixed-citation></ref><ref id="ref54"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Peters</surname><given-names>A</given-names></name>
</person-group>:
<article-title>The energy request of inflammation.</article-title>
<source>
<italic toggle="yes">Endocrinology.</italic>
</source>
<year>2006</year>;<volume>147</volume>(<issue>10</issue>):<fpage>4550</fpage>&#x02013;<lpage>4552</lpage>.
<pub-id pub-id-type="doi">10.1210/en.2006-0815</pub-id>
<pub-id pub-id-type="pmid">16980440</pub-id>
</mixed-citation></ref><ref id="ref55"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bradfute</surname><given-names>SB</given-names></name>
<name><surname>Swanson</surname><given-names>PE</given-names></name>
<name><surname>Smith</surname><given-names>MA</given-names></name>
<etal/>
</person-group>:
<article-title>Mechanisms and consequences of Ebolavirus-induced Lymphocyte apoptosis.</article-title>
<source>
<italic toggle="yes">J. Immunol.</italic>
</source>
<year>2010</year>;<volume>184</volume>:<fpage>327</fpage>&#x02013;<lpage>335</lpage>.
<pub-id pub-id-type="doi">10.4049/jimmunol.0901231</pub-id>
<pub-id pub-id-type="pmid">20028660</pub-id>
</mixed-citation></ref><ref id="ref56"><label>58</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>Y</given-names></name>
<name><surname>Altman</surname><given-names>BJ</given-names></name>
<name><surname>Coloff</surname><given-names>JLHCE</given-names></name>
<etal/>
</person-group>:
<article-title>Glycogen synthase kinase 3 alpha and 3 beta mediate a glucose-sensitive antiapoptotic signalling pathway to stabilize McI-l.</article-title>
<source>
<italic toggle="yes">Mol. Cell. Biol.</italic>
</source>
<year>2007</year>;<volume>27</volume>:<fpage>4328</fpage>&#x02013;<lpage>4339</lpage>.
<pub-id pub-id-type="doi">10.1128/MCB.00153-07</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC1900055</pub-id>-->
<pub-id pub-id-type="pmid">17371841</pub-id>
</mixed-citation></ref><ref id="ref57"><label>59</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dube</surname><given-names>D</given-names></name>
<name><surname>Schornberg</surname><given-names>KL</given-names></name>
<name><surname>Shoemaker</surname><given-names>CJ</given-names></name>
<etal/>
</person-group>:
<article-title>Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry.</article-title>
<source>
<italic toggle="yes">PNAS.</italic>
</source>
<year>2010</year>;<volume>107</volume>:<fpage>16637</fpage>&#x02013;<lpage>16642</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1008509107</pub-id>
<pub-id pub-id-type="pmid">20817853</pub-id>
</mixed-citation></ref><ref id="ref58"><label>60</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dwyer</surname><given-names>DS</given-names></name>
<name><surname>Pinkofsky</surname><given-names>HB</given-names></name>
<name><surname>Liu</surname><given-names>Y</given-names></name>
<etal/>
</person-group>:
<article-title>Attachment of PC12 cells to adhesion substratum induces the accumulation of glucose transporters and stimulates glucose metabolism.</article-title>
<source>
<italic toggle="yes">Neurochem. Res.</italic>
</source>
<year>1998</year>;<volume>23</volume>:<fpage>1107</fpage>&#x02013;<lpage>1116</lpage>.
<pub-id pub-id-type="doi">10.1023/A:1020768321358</pub-id>
<pub-id pub-id-type="pmid">9704601</pub-id>
</mixed-citation></ref><ref id="ref59"><label>61</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wool Lewis</surname><given-names>RJ</given-names></name>
<name><surname>Bates</surname><given-names>P</given-names></name>
</person-group>:
<article-title>Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell-lines.</article-title>
<source>
<italic toggle="yes">J. Virol.</italic>
</source>
<year>1998</year>;<volume>72</volume>:<fpage>3155</fpage>&#x02013;<lpage>3160</lpage>.
<pub-id pub-id-type="doi">10.1128/JVI.72.4.3155-3160.1998</pub-id>
<pub-id pub-id-type="pmid">9525641</pub-id>
</mixed-citation></ref><ref id="ref60"><label>62</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cui</surname><given-names>J</given-names></name>
<name><surname>Yuan</surname><given-names>X</given-names></name>
<name><surname>Wang</surname><given-names>L</given-names></name>
<etal/>
</person-group>:
<article-title>Recent Loss of Vitamin C Biosynthesis Ability in Bats.</article-title>
<source>
<italic toggle="yes">PLoS One.</italic>
</source>
<year>2011</year>;<volume>6</volume>(<issue>11</issue>): e27114.
<pub-id pub-id-type="doi">10.1371/journal.pone.0027114</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC3206078</pub-id>-->
<pub-id pub-id-type="pmid">22069493</pub-id>
</mixed-citation></ref><ref id="ref61"><label>63</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cui</surname><given-names>J</given-names></name>
<name><surname>Pan</surname><given-names>YH</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<etal/>
</person-group>:
<article-title>Progressive pseudogenization: vitamin C synthesis and its loss in bats.</article-title>
<source>
<italic toggle="yes">Mol. Biol. Evol.</italic>
</source>
<year>2011</year>;<volume>28</volume>:<fpage>1025</fpage>&#x02013;<lpage>1031</lpage>.
<pub-id pub-id-type="doi">10.1093/molbev/msq286</pub-id>
<pub-id pub-id-type="pmid">21037206</pub-id>
</mixed-citation></ref><ref id="ref62"><label>64</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Olival</surname><given-names>KJ</given-names></name>
<name><surname>Islam</surname><given-names>A</given-names></name>
<name><surname>Yu</surname><given-names>M</given-names></name>
<etal/>
</person-group>:
<article-title>Ebola virus antibodies in fruit bats.</article-title>
<source>
<italic toggle="yes">Bangladesh. Emerg. Infect. Dis.</italic>
</source>
<year>2013</year>;<volume>19</volume>:<fpage>270</fpage>&#x02013;<lpage>273</lpage>.
<pub-id pub-id-type="doi">10.3201/eid1902.120524</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC3559038</pub-id>-->
<pub-id pub-id-type="pmid">23343532</pub-id>
</mixed-citation></ref><ref id="ref63"><label>65</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Towner</surname><given-names>JS</given-names></name>
<name><surname>Amman</surname><given-names>BR</given-names></name>
<name><surname>Sealy</surname><given-names>TK</given-names></name>
<etal/>
</person-group>:
<article-title>Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats.</article-title>
<source>
<italic toggle="yes">PLoS Pathog.</italic>
</source>
<year>2009</year>;<volume>5</volume>(<issue>7</issue>):e1000536.
<pub-id pub-id-type="doi">10.1371/journal.ppat.1000536</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC2713404</pub-id>-->
<pub-id pub-id-type="pmid">19649327</pub-id>
</mixed-citation></ref><ref id="ref64"><label>66</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shen</surname><given-names>B</given-names></name>
<name><surname>Han</surname><given-names>X</given-names></name>
<name><surname>Zhang</surname><given-names>J</given-names></name>
<etal/>
</person-group>:
<article-title>Adaptive Evolution in the Glucose Transporter 4 Gene Slc2a4 in Old World Fruit Bats (Family: Pteropodidae).</article-title>
<source>
<italic toggle="yes">PLoS One.</italic>
</source>
<year>2012</year>;<volume>7</volume>(<issue>4</issue>): e33197.
<pub-id pub-id-type="doi">10.1371/journal.pone.0033197</pub-id>
</mixed-citation></ref><ref id="ref65"><label>67</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tracy</surname><given-names>CR</given-names></name>
<name><surname>McWhorter</surname><given-names>TJ</given-names></name>
<name><surname>Korine</surname><given-names>C</given-names></name>
<etal/>
</person-group>:
<article-title>Absorption of sugars in the Egyptian fruit bat (Rousettus aegyptiacus): a paradox explained.</article-title>
<source>
<italic toggle="yes">J. Exp. Biol.</italic>
</source>
<year>2007</year>;<volume>210</volume>(<issue>Pt 10</issue>):<fpage>1726</fpage>&#x02013;<lpage>1734</lpage>.
<pub-id pub-id-type="doi">10.1242/jeb.02766</pub-id>
<pub-id pub-id-type="pmid">17488935</pub-id>
</mixed-citation></ref><ref id="ref66"><label>68</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>ZY</given-names></name>
<name><surname>Duckers</surname><given-names>HJ</given-names></name>
<name><surname>Sullivan</surname><given-names>NJ</given-names></name>
<etal/>
</person-group>:
<article-title>Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.</article-title>
<source>
<italic toggle="yes">Nat. Med.</italic>
</source>
<year>2000 Aug</year>;<volume>6</volume>(<issue>8</issue>):<fpage>886</fpage>&#x02013;<lpage>889</lpage>.
<pub-id pub-id-type="doi">10.1038/78645</pub-id>
<pub-id pub-id-type="pmid">10932225</pub-id>
</mixed-citation></ref><ref id="ref67"><label>69</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fedeli</surname><given-names>C</given-names></name>
<name><surname>Torriani</surname><given-names>G</given-names></name>
<name><surname>Galan-Navarro</surname><given-names>C</given-names></name>
<etal/>
</person-group>:
<article-title>Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan.</article-title>
<source>
<italic toggle="yes">J. Virol.</italic>
</source>
<year>2018 Feb 12</year>;<volume>92</volume>(<issue>5</issue>):<fpage>e01613</fpage>&#x02013;<lpage>e01617</lpage>.
<pub-id pub-id-type="doi">10.1128/JVI.01613-17</pub-id>
<!--<pub-id pub-id-type="pmcid">PMC5809728</pub-id>-->
<pub-id pub-id-type="pmid">29237830</pub-id>
</mixed-citation></ref></ref-list></back><sub-article article-type="reviewer-report" id="report346870"><front-stub><article-id pub-id-type="doi">10.5256/f1000research.175501.r346870</article-id><title-group><article-title>Reviewer response for version 6</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Hong-Li</given-names></name><xref rid="r346870a1" ref-type="aff">1</xref><role>Referee</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3292-6134</contrib-id></contrib><aff id="r346870a1">
<label>1</label>Xi'an People's Hospital, Xi'an, China</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>12</month><year>2024</year></pub-date><permissions><copyright-statement>Copyright: &#x000a9; 2024 Liu HL</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article related-article-type="peer-reviewed-article" ext-link-type="doi" id="relatedArticleReport346870" xlink:href="10.12688/f1000research.134121.6">Version 6</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve</meta-value></custom-meta></custom-meta-group></front-stub><body><p>I have read the revised manuscript and better understand the paper. The authors made an appropriate and sufficient revision, and I will approve the indexing of this paper. Thanks a lot and have a good day.</p><p>Is the topic of the opinion article discussed accurately in the context of the current literature?</p><p>Partly</p><p>Are arguments sufficiently supported by evidence from the published literature?</p><p>Yes</p><p>Are all factual statements correct and adequately supported by citations?</p><p>Yes</p><p>Are the conclusions drawn balanced and justified on the basis of the presented arguments?</p><p>Partly</p><p>Reviewer Expertise:</p><p>NA</p><p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p></body></sub-article><sub-article article-type="reviewer-report" id="report339488"><front-stub><article-id pub-id-type="doi">10.5256/f1000research.173777.r339488</article-id><title-group><article-title>Reviewer response for version 5</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Qin</surname><given-names>Chao</given-names></name><xref rid="r339488a1" ref-type="aff">1</xref><role>Referee</role></contrib><aff id="r339488a1">
<label>1</label>University of Southern California, Los Angeles, California, USA</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>29</day><month>11</month><year>2024</year></pub-date><permissions><copyright-statement>Copyright: &#x000a9; 2024 Qin C</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article related-article-type="peer-reviewed-article" ext-link-type="doi" id="relatedArticleReport339488" xlink:href="10.12688/f1000research.134121.5">Version 5</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve</meta-value></custom-meta></custom-meta-group></front-stub><body><p>This manuscript described a the correlation of metabolic receptors and virus induced diseases. It is a good topic to discuss. I would like the authors to address following issues in the manuscript.</p><p> 1. Please use more condensed languages for the statements, as well as the titles and subtitles.</p><p> 2. Please spell out the acronym at the first time of using it.&#x000a0;</p><p> 3. The original function of metabolic receptors such as GLUT1 should be explained in more details, as well as the role of glycolysis in filovirus infection. This will highlight the unique role GLUT1 in viral infection.</p><p>Is the topic of the opinion article discussed accurately in the context of the current literature?</p><p>Yes</p><p>Are arguments sufficiently supported by evidence from the published literature?</p><p>Yes</p><p>Are all factual statements correct and adequately supported by citations?</p><p>Yes</p><p>Are the conclusions drawn balanced and justified on the basis of the presented arguments?</p><p>Yes</p><p>Reviewer Expertise:</p><p>Metabolism; Viral infection; Immunology</p><p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p></body><sub-article article-type="response" id="comment12994-339488"><front-stub><contrib-group><contrib contrib-type="author"><name><surname>Chicano Wust</surname><given-names>Ivan</given-names></name><aff>-, Universidad Nacional de Educacion a Distancia, Madrid, Community of Madrid, Spain</aff></contrib></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>19</day><month>12</month><year>2024</year></pub-date></front-stub><body><p>Thank you for appreciating my effort and giving me some clues to improve the article.</p></body></sub-article></sub-article><sub-article article-type="reviewer-report" id="report339493"><front-stub><article-id pub-id-type="doi">10.5256/f1000research.173777.r339493</article-id><title-group><article-title>Reviewer response for version 5</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Hong-Li</given-names></name><xref rid="r339493a1" ref-type="aff">1</xref><role>Referee</role><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3292-6134</contrib-id></contrib><aff id="r339493a1">
<label>1</label>Xi'an People's Hospital, Xi'an, China</aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>29</day><month>11</month><year>2024</year></pub-date><permissions><copyright-statement>Copyright: &#x000a9; 2024 Liu HL</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article related-article-type="peer-reviewed-article" ext-link-type="doi" id="relatedArticleReport339493" xlink:href="10.12688/f1000research.134121.5">Version 5</related-article><custom-meta-group><custom-meta><meta-name>recommendation</meta-name><meta-value>approve-with-reservations</meta-value></custom-meta></custom-meta-group></front-stub><body><p>1. Rational use of punctuation to simplify sentence structure which makes it easy for readers to get the point of the paper;</p><p> 2. What is the most important purpose of this paper? The viral hemorrhagic fever or filovirus-related hemorrhagic fever? If the purpose is the latter, what is filovirus&#x0ff1f;which viruses are included in filovirus? it will be better for the author to make an introduction;</p><p> 3. The title talks about the relationship between the TIM-1, TAM, Glut-1, and the manifestation of viral hemorrhagic fever, and the Lassa virus, and dengue virus were mentioned in the text. If the authors want to present the relationship between these receptors and viral-related hemorrhagic fever. Actually, the Hantavirus is also a major agent of hemorrhagic fever that needs to pay attention;</p><p> 4. As the authors pointed out "the manifestations of thrombotic microangiopathic hemolytic anemia were similar to those of filovirus hemorrhagic fever", why did the authors mention this content? Or the TIM, Glut-1 is associated with this disorder?</p><p> 5. The concluding remarks should be precise and clear. The conclusion part is a summary but not a stacking of references or it will be hard for readers to get the main point of the paper;</p><p> 6. It is necessary for authors to reconstruct the manuscript. From the main topic, the introduction of receptor-related biological functions, the viruses that can cause hemorrhagic fever, and the relationship between these two parts involving the&#x000a0; possible pathways or mechanisms, and then conclude that&#x000a0; the pivotal role of these receptors in the viral-related hemorrhagic fever and their possible value in the treatment of these diseases.</p><p>Is the topic of the opinion article discussed accurately in the context of the current literature?</p><p>Partly</p><p>Are arguments sufficiently supported by evidence from the published literature?</p><p>Yes</p><p>Are all factual statements correct and adequately supported by citations?</p><p>Yes</p><p>Are the conclusions drawn balanced and justified on the basis of the presented arguments?</p><p>Partly</p><p>Reviewer Expertise:</p><p>infectious disease; HFRS; immunology</p><p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p></body><sub-article article-type="response" id="comment12995-339493"><front-stub><contrib-group><contrib contrib-type="author"><name><surname>Chicano Wust</surname><given-names>Ivan</given-names></name><aff>-, Universidad Nacional de Educacion a Distancia, Madrid, Community of Madrid, Spain</aff></contrib></contrib-group><author-notes><fn fn-type="COI-statement"><p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p></fn></author-notes><pub-date pub-type="epub"><day>19</day><month>12</month><year>2024</year></pub-date></front-stub><body><p>Thank you for giving me the opportunity to improve the last version of the article.</p></body></sub-article></sub-article></article>